GoHealth (NASDAQ:GOCO - Get Free Report) is expected to be releasing its earnings data before the market opens on Thursday, March 13th. Analysts expect GoHealth to post earnings of $1.16 per share and revenue of $326.56 million for the quarter. Persons interested in listening to the company's earnings conference call can do so using this link.
GoHealth Stock Performance
Shares of GOCO traded down $0.59 during trading hours on Friday, reaching $15.05. 31,283 shares of the company traded hands, compared to its average volume of 31,501. The stock's fifty day moving average is $15.86 and its 200 day moving average is $12.40. The stock has a market cap of $344.74 million, a P/E ratio of -4.30 and a beta of 1.68. The company has a debt-to-equity ratio of 1.72, a quick ratio of 1.18 and a current ratio of 1.18. GoHealth has a 1-year low of $7.27 and a 1-year high of $21.00.
Institutional Inflows and Outflows
An institutional investor recently raised its position in GoHealth stock. Bank of America Corp DE grew its stake in shares of GoHealth, Inc. (NASDAQ:GOCO - Free Report) by 22.8% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 7,831 shares of the company's stock after buying an additional 1,452 shares during the period. Bank of America Corp DE's holdings in GoHealth were worth $105,000 as of its most recent filing with the SEC. 24.21% of the stock is currently owned by hedge funds and other institutional investors.
GoHealth Company Profile
(
Get Free Report)
GoHealth, Inc operates as a health insurance marketplace and Medicare-focused digital health company in the United States. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs.
Recommended Stories

Before you consider GoHealth, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GoHealth wasn't on the list.
While GoHealth currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.